Lymphocytic choriomeningitis virus meningitis after needlestick injury: a case report.


Journal

Antimicrobial resistance and infection control
ISSN: 2047-2994
Titre abrégé: Antimicrob Resist Infect Control
Pays: England
ID NLM: 101585411

Informations de publication

Date de publication:
2019
Historique:
received: 14 11 2018
accepted: 16 04 2019
entrez: 30 5 2019
pubmed: 30 5 2019
medline: 28 5 2020
Statut: epublish

Résumé

Needlestick accidents while handling of infectious material in research laboratories can lead to life-threatening infections in laboratory personnel. In laboratories working with the lymphocytic choriomeningitis virus (LCMV), the virus can be transmitted to humans through needlestick injury and lead to serious acute illness up to meningitis. We report of a case of LCMV meningitis in a laboratory worker who sustained a penetrating needlestick injury with a LCMV-contaminated hollow needle whilst disposing of a used syringe into the sharps waste bin. Four days after needlestick injury the laboratory worker developed a systemic disease: 11 days after exposure, she was diagnosed with meningitis with clinical signs and symptoms of meningismus, photophobia, nausea and vomiting, requiring hospitalisation. The PCR was positive for LCMV from the blood sample. 18 days after exposure, seroconversion confirmed the diagnosis of LCMV-induced meningitis with an increase in specific LCMV-IgM antibodies to 1:10'240 (day 42: 1:20'480). Ten weeks after exposure, a follow-up titre for IgM returned negative, whereas IgG titre increased to 1:20'480. This is the first case report of a PCR-documented LCMV meningitis, coupled with seroconversion, following needlestick injury. It highlights the importance of infection prevention practices that comprise particularly well established safety precaution protocols in research laboratories handling this pathogenic virus, because exposure to even a small amount of LCMV can lead to a severe, life-threatening infection.

Sections du résumé

Background
Needlestick accidents while handling of infectious material in research laboratories can lead to life-threatening infections in laboratory personnel. In laboratories working with the lymphocytic choriomeningitis virus (LCMV), the virus can be transmitted to humans through needlestick injury and lead to serious acute illness up to meningitis.
Case presentation
We report of a case of LCMV meningitis in a laboratory worker who sustained a penetrating needlestick injury with a LCMV-contaminated hollow needle whilst disposing of a used syringe into the sharps waste bin. Four days after needlestick injury the laboratory worker developed a systemic disease: 11 days after exposure, she was diagnosed with meningitis with clinical signs and symptoms of meningismus, photophobia, nausea and vomiting, requiring hospitalisation. The PCR was positive for LCMV from the blood sample. 18 days after exposure, seroconversion confirmed the diagnosis of LCMV-induced meningitis with an increase in specific LCMV-IgM antibodies to 1:10'240 (day 42: 1:20'480). Ten weeks after exposure, a follow-up titre for IgM returned negative, whereas IgG titre increased to 1:20'480.
Conclusions
This is the first case report of a PCR-documented LCMV meningitis, coupled with seroconversion, following needlestick injury. It highlights the importance of infection prevention practices that comprise particularly well established safety precaution protocols in research laboratories handling this pathogenic virus, because exposure to even a small amount of LCMV can lead to a severe, life-threatening infection.

Identifiants

pubmed: 31139360
doi: 10.1186/s13756-019-0524-4
pii: 524
pmc: PMC6528361
doi:

Substances chimiques

Antibodies, Viral 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

77

Commentaires et corrections

Type : ErratumIn

Déclaration de conflit d'intérêts

Competing interestsThe authors declare that they have no competing interests.

Références

Occup Med (Lond). 2016 Mar;66(2):171-3
pubmed: 26416845
N Engl J Med. 2006 May 25;354(21):2235-49
pubmed: 16723615
Clin Infect Dis. 1996 Jan;22(1):197
pubmed: 8825010
N Engl J Med. 1966 Apr 28;274(17):934-6
pubmed: 5948615
Am J Epidemiol. 1975 Feb;101(2):103-10
pubmed: 1092154
J Virol Methods. 2011 Oct;177(1):118-22
pubmed: 21763351
N Engl J Med. 2008 Mar 6;358(10):991-8
pubmed: 18256387
JAMA. 1992 Mar 11;267(10):1349-53
pubmed: 1740856
Pediatr Infect Dis J. 1993 Nov;12(11):942-6
pubmed: 8265286
Emerg Infect Dis. 2014 Feb;20(2):240-7
pubmed: 24447605
Emerg Infect Dis. 2007 Mar;13(3):472-5
pubmed: 17552104
Trans R Soc Trop Med Hyg. 2007 Dec;101(12):1253-64
pubmed: 17905372

Auteurs

Sarah Dräger (S)

1Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Petersgraben 4, 4031 Basel, Switzerland.

Anna-Friederike Marx (AF)

2Department of Biomedicine - Haus Petersplatz, Division of Experimental Virology, University of Basel, 4009 Basel, Switzerland.

Fiona Pigny (F)

3Laboratory of Virology, Department of Genetic and Laboratory Medicine, University Hospitals of Geneva, Rue Gabrielle-Perret-Gentil 4, 1211, 14 Geneva, Switzerland.

Pascal Cherpillod (P)

3Laboratory of Virology, Department of Genetic and Laboratory Medicine, University Hospitals of Geneva, Rue Gabrielle-Perret-Gentil 4, 1211, 14 Geneva, Switzerland.

Philip Eisermann (P)

4WHO Collaborating Centre for Arbovirus and Haemorrhagic Fever Reference and Research, Bernhard Nocht Institute for Tropical Medicine, Bernhard-Nocht-Strasse 74, 20359 Hamburg, Germany.

Parham Sendi (P)

1Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Petersgraben 4, 4031 Basel, Switzerland.
5Institute for Infectious Diseases, University of Bern, Freiburgstrasse 18, 3010 Bern, Switzerland.

Andreas F Widmer (AF)

1Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Petersgraben 4, 4031 Basel, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH